pubmed-article:17112845 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C1709854 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C0376622 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C1704939 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C1823242 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:17112845 | lifeskim:mentions | umls-concept:C1515568 | lld:lifeskim |
pubmed-article:17112845 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:17112845 | pubmed:dateCreated | 2006-11-20 | lld:pubmed |
pubmed-article:17112845 | pubmed:abstractText | Single nucleotide polymorphisms (SNPs) in the multidrug resistance (MDR1) gene correlate with the intestinal function of P-glycoprotein (PGP). PGP serves as a hydrophobic export pump that extrudes cyclosporine (CsA) across the luminal membrane thus preventing CsA absorption. These genetic variants may predict CsA exposure levels in the early posttransplantation period. | lld:pubmed |
pubmed-article:17112845 | pubmed:language | eng | lld:pubmed |
pubmed-article:17112845 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17112845 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17112845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17112845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17112845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17112845 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17112845 | pubmed:month | Nov | lld:pubmed |
pubmed-article:17112845 | pubmed:issn | 0041-1345 | lld:pubmed |
pubmed-article:17112845 | pubmed:author | pubmed-author:FraserAA | lld:pubmed |
pubmed-article:17112845 | pubmed:author | pubmed-author:GreenSS | lld:pubmed |
pubmed-article:17112845 | pubmed:author | pubmed-author:BelitskyPP | lld:pubmed |
pubmed-article:17112845 | pubmed:author | pubmed-author:KiberdB ABA | lld:pubmed |
pubmed-article:17112845 | pubmed:author | pubmed-author:NashanBB | lld:pubmed |
pubmed-article:17112845 | pubmed:author | pubmed-author:LawenJJ | lld:pubmed |
pubmed-article:17112845 | pubmed:author | pubmed-author:FooteC JCJ | lld:pubmed |
pubmed-article:17112845 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17112845 | pubmed:volume | 38 | lld:pubmed |
pubmed-article:17112845 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17112845 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17112845 | pubmed:pagination | 2847-9 | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:meshHeading | pubmed-meshheading:17112845... | lld:pubmed |
pubmed-article:17112845 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:17112845 | pubmed:articleTitle | MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients. | lld:pubmed |
pubmed-article:17112845 | pubmed:affiliation | Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. | lld:pubmed |
pubmed-article:17112845 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:5243 | entrezgene:pubmed | pubmed-article:17112845 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17112845 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17112845 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17112845 | lld:pubmed |